Elissa Zirinsky1, Elijah Paintsil1,2,3, Carlos R Oliveira1. 1. Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale University School of Medicine. 2. Department of Pharmacology, Yale University School of Medicine. 3. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Abstract
PURPOSE OF REVIEW: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has exacerbated the longstanding racial/ethnic health disparities in the USA, with a disproportionately negative effect on children of color. This review summarizes recently published studies that describe the clinical epidemiology and racial/ethnic disparities associated with SARS-CoV-2 in children. RECENT FINDINGS: Children with SARS-CoV-2 infections manifest with a wide spectrum of disease. Most are either asymptomatic or mildly symptomatic with fever, gastrointestinal, and/or upper respiratory disease. Some children can progress to develop severe lower respiratory disease or a hyper-inflammatory, Kawasaki-like syndrome leading to cardiovascular shock. Although SARS-CoV-2-related deaths in children are rare, more children died within the first nine months of the pandemic than have died during any influenza season over the last decade.Black and Hispanic children represent less than 41% of the US population but account for three out of every four SARS-CoV-2-related hospitalizations and deaths in the USA. The drivers of these disparities in children are complex and likely a combination of societal, biological, and behavioral influences. SUMMARY: This pandemic brought to light longstanding health disparities in historically marginalized populations, and minority children have suffered tremendously. It provides an opportunity to understand how a virus hijacked deep-rooted inequities, address these inequities, and work to prevent this outcome in future pandemics/epidemics.
PURPOSE OF REVIEW: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has exacerbated the longstanding racial/ethnic health disparities in the USA, with a disproportionately negative effect on children of color. This review summarizes recently published studies that describe the clinical epidemiology and racial/ethnic disparities associated with SARS-CoV-2 in children. RECENT FINDINGS: Children with SARS-CoV-2 infections manifest with a wide spectrum of disease. Most are either asymptomatic or mildly symptomatic with fever, gastrointestinal, and/or upper respiratory disease. Some children can progress to develop severe lower respiratory disease or a hyper-inflammatory, Kawasaki-like syndrome leading to cardiovascular shock. Although SARS-CoV-2-related deaths in children are rare, more children died within the first nine months of the pandemic than have died during any influenza season over the last decade.Black and Hispanic children represent less than 41% of the US population but account for three out of every four SARS-CoV-2-related hospitalizations and deaths in the USA. The drivers of these disparities in children are complex and likely a combination of societal, biological, and behavioral influences. SUMMARY: This pandemic brought to light longstanding health disparities in historically marginalized populations, and minority children have suffered tremendously. It provides an opportunity to understand how a virus hijacked deep-rooted inequities, address these inequities, and work to prevent this outcome in future pandemics/epidemics.
Authors: Katherine A Auger; Samir S Shah; Troy Richardson; David Hartley; Matthew Hall; Amanda Warniment; Kristen Timmons; Dianna Bosse; Sarah A Ferris; Patrick W Brady; Amanda C Schondelmeyer; Joanna E Thomson Journal: JAMA Date: 2020-09-01 Impact factor: 56.272
Authors: Philip Zachariah; Candace L Johnson; Katia C Halabi; Danielle Ahn; Anita I Sen; Avital Fischer; Sumeet L Banker; Mirna Giordano; Christina S Manice; Rebekah Diamond; Taylor B Sewell; Adam J Schweickert; John R Babineau; R Colin Carter; Daniel B Fenster; Jordan S Orange; Teresa A McCann; Steven G Kernie; Lisa Saiman Journal: JAMA Pediatr Date: 2020-10-05 Impact factor: 16.193
Authors: Elizabeth M Painter; Emily N Ussery; Anita Patel; Michelle M Hughes; Elizabeth R Zell; Danielle L Moulia; Lynn Gibbs Scharf; Michael Lynch; Matthew D Ritchey; Robin L Toblin; Bhavini Patel Murthy; LaTreace Q Harris; Annemarie Wasley; Dale A Rose; Amanda Cohn; Nancy E Messonnier Journal: MMWR Morb Mortal Wkly Rep Date: 2021-02-05 Impact factor: 17.586
Authors: Laura E Flores; Walter R Frontera; Michele P Andrasik; Carlos Del Rio; Antonio Mondríguez-González; Stephanie A Price; Elizabeth M Krantz; Steven A Pergam; Julie K Silver Journal: JAMA Netw Open Date: 2021-02-01
Authors: Lindsay Kim; Michael Whitaker; Alissa O'Halloran; Anita Kambhampati; Shua J Chai; Arthur Reingold; Isaac Armistead; Breanna Kawasaki; James Meek; Kimberly Yousey-Hindes; Evan J Anderson; Kyle P Openo; Andy Weigel; Patricia Ryan; Maya L Monroe; Kimberly Fox; Sue Kim; Ruth Lynfield; Erica Bye; Sarah Shrum Davis; Chad Smelser; Grant Barney; Nancy L Spina; Nancy M Bennett; Christina B Felsen; Laurie M Billing; Jessica Shiltz; Melissa Sutton; Nicole West; H Keipp Talbot; William Schaffner; Ilene Risk; Andrea Price; Lynnette Brammer; Alicia M Fry; Aron J Hall; Gayle E Langley; Shikha Garg Journal: MMWR Morb Mortal Wkly Rep Date: 2020-08-14 Impact factor: 17.586
Authors: Carlos R Oliveira; Linda M Niccolai; Hassan Sheikha; Lina Elmansy; Chaney C Kalinich; Nathan D Grubaugh; Eugene D Shapiro Journal: JAMA Netw Open Date: 2022-03-01